Inventor
BOYCE CHRISTOPHER W
US26 patents
⚠️ This page may combine multiple inventors who share the name “BOYCE CHRISTOPHER W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
9 patentsUS7220735B2May 22, 2007
Benzimidazolone histamine H3 antagonists
SCHERING CORP31 citations92
US7105505B2Sep 12, 2006
Benzimidazole derivatives useful as histamine H3 antagonists
SCHERING CORP27 citations92
US6720328B2Apr 13, 2004
Non-imidazole compounds
SCHERING CORP31 citations92
US8003624B2Aug 23, 2011
Functionally selective ALPHA2C adrenoreceptor agonists
SCHERING CORP11 citations84
US7300941B2Nov 27, 2007
Non-imidazole compounds
SCHERING CORP11 citations84
US7638531B2Dec 29, 2009
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
SCHERING CORP19 citations83
US7700592B2Apr 20, 2010
α2C adrenoreceptor agonists
SCHERING CORP8 citations82
US7635705B2Dec 22, 2009
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
SCHERING CORP2 citations62
US8017642B2Sep 13, 2011
Functionally selective ALPHA2C adrenoreceptor agonists
SCHERING CORP0 citations52
MERCK SHARP & DOHME
7 patentsUS8383818B2Feb 26, 2013
Functionally selective alpha2C adrenoreceptor agonists
MERCK SHARP & DOHME5 citations72
US11344496B2May 31, 2022
Methods for preparing stabilized amorphous drug formulations using acoustic fusion
MERCK SHARP & DOHME0 citations56
US10759805B2Sep 1, 2020
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations51
US10065967B2Sep 4, 2018
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations51
US9745307B2Aug 29, 2017
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations51
US8569312B2Oct 29, 2013
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
MERCK SHARP & DOHME0 citations51
US8476274B2Jul 2, 2013
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
MERCK SHARP & DOHME0 citations51